San Antonio, TX – According to filings with the U.S. Securities and Exchange Commission, VeraDermics is raising $22,238,328.00 in new funding. Sources indicate as part of senior management President, Timothy Durso played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About VeraDermics
VeraDermics is a small, dermatology-focused company with a promising combination product in its pipeline. At VeraDermics Inc., were taking the fear and pain out of pediatric wart treatment. Current wart treatments are anything but kid-friendly. Our founders believe that every kid deserves to have a safe, effective, and easy cure for their warts. To solve the problems with current wart treatments, we invented the 1st ever kid-friendly and easy-to-use wart treatment. Our product, WartPatch, combines the most effective wart treatment with a kid-friendly drug delivery platform. .

To learn more about VeraDermics, visit http://www.veradermics.com/

Contact:
Timothy Durso, President
847-641-0412
https://www.linkedin.com/in/timothy-durso-5922bb87/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved